Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Merck Statement In Response To The FDA's June 12, 2009 Communication With Updated Information On Leukotriene Inhibitors, Including SINGULAIR(R)
Merck & Co., Inc. issued the following statement in response to today"s communication from the U.S. Food & Drug Administration (FDA) addressing updated information on leukotriene inhibitors, including SINGULAIR® (montelukast sodium).
generic viagra online
New Medicare Rules On Oxygen Suppliers Worry Patients
Complex new Medicare rules that seek to cut costs of home-oxygen therapy are confusing the more than one million people who rely on the federal insurer to pay for the coverage.
News of the day
Prevention Is The Highlight Theme Of This Year's ESC Congress
As the ESC Congress 2009 draws ever closer, the evidence in favour of a healthy lifestyle for the prevention of cardiovascular disease grows ever stronger. Prevention is the highlight theme of this year"s event, which will take place in Barcelona from 29 August to 2 September. Lifestyle factors are heavily on the agenda.
Cardiovascular

Warning To Consumers About Recreational Use Of Medicines, Australia

The National Prescribing Service (NPS) warns people are playing Russian roulette with their health when they take medicines inappropriately. Media reports this week about people mixing sleeping tablet, zolpidem (Stilnox), with energy drink Red Bull™ have failed to highlight the risks people are taking when they intentionally misuse pharmaceuticals. NPS CEO, Dr Lynn Weekes says people should ensure they know the risks and benefits of any medicine before taking it. "All medicines have potential side effects and should only be used for the purpose in which they have been prescribed," Dr Weekes said. Zolpidem is a prescription medicine that is used to initiate and maintain sleep in those with sleeping difficulties. It has a number of common side effects, including drowsiness, dizziness, diarrhoea, nausea, vomiting, headache and muscle weakness. It has also been associated with reports of unusual and potentially dangerous behaviours during sleep. The consumer medicine information for Stilnox, which is written by the manufacturer, clearly states that Stilnox should not be taken if you have been drinking alcohol and it should not be given to people under the age of 18. "I strongly advise anyone who has been, or is thinking about, using any medicine for recreational purposes to read the consumer medicine information leaflet and think about the ramifications it may have on their health," Dr Weekes said. "There are many s for information about medicines including your pharmacist or GP, the NPS website and our publications." "Health professionals should also be aware of patients who may ask specifically for Stilnox following these latest media reports and ensure patients understand the purpose for which the medicine has been prescribed," Dr Weekes warned. Consumer medicine information leaflets can be viewed here. Additional information about zolpidem is available in the December 2008 edition of Australian Prescriber in "Hypnotic hazards: adverse effects of zolpidem and other z-drugs" by Professor LG Olson. To view the article visit here. The National Prescribing Service Limited


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009